Medistem Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (2005)
Status: Acquired by Intrexon (2013)

Organization Overview

First Clinical Trial
2012
NCT01558908
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Neil H. Riordan PhD